These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Grey matter atrophy in patients suffering from multiple sclerosis.
    Author: Kincses ZT, Tóth E, Bankó N, Veréb D, Szabó N, Csete G, Faragó P, Király A, Bencsik K, Vécsei L.
    Journal: Ideggyogy Sz; 2014 Sep 30; 67(9-10):293-300. PubMed ID: 25518257.
    Abstract:
    White matter lesions are defining characteristics of multiple sclerosis (MS), whereas grey matter involvement is a less recognised attribute. Recent investigations using dedicated imaging approaches have made it possible to depict cortical lesions. Additionally, grey matter atrophy may be estimated using various methods. Several studies have suggested that grey matter atrophy closely correlates to clinical disability. In this review we have collected information on grey matter atrophy in MS and the effect of disease modifying therapies upon brain atrophy.
    [Abstract] [Full Text] [Related] [New Search]